BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6537913)

  • 1. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer.
    Wang DY; Knyba RE; Bulbrook RD; Millis RR; Hayward JL
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):25-31. PubMed ID: 6537913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen as a monitor of recurrent breast cancer.
    Lee YT
    J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.
    Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E
    Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of CEA in breast cancer.
    Gray BN
    Aust N Z J Surg; 1984 Feb; 54(1):1-2. PubMed ID: 6586160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls.
    Rimsten A; Adami HO; Wahren B; Nordin B
    Br J Cancer; 1979 Feb; 39(2):109-15. PubMed ID: 435362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma.
    Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA
    Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
    Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
    Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
    Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
    J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinicopathological study on carcinoembryonic antigen in breast cancer].
    Asagoe T; Yamoto H; Hanatani Y; Horie F; Nemoto A; Kidooka K; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):793-8. PubMed ID: 2370434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator.
    Shousha S; Lyssiotis T; Godfrey VM; Scheuer PJ
    Br Med J; 1979 Mar; 1(6166):777-9. PubMed ID: 435793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R; Caffier H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
    Safi F; Kohler I; Röttinger E; Beger H
    Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen immunocytochemistry in primary breast cancer.
    Robertson JF; Ellis IO; Bell J; Todd JH; Robins A; Elston CW; Blamey RW
    Cancer; 1989 Oct; 64(8):1638-45. PubMed ID: 2790676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
    Theriault RL; Hortobagyi GN; Fritsche HA; Frye D; Martinez R; Buzdar AU
    Cancer; 1989 Mar; 63(5):828-35. PubMed ID: 2914290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.
    Bhatavdekar JM; Balar DB; Shah NG; Trivedi SN; Bhaduri A; Patel DD; Karelia NH; Shukla MK; Ghosh N
    Tumour Biol; 1987; 8(5):233-40. PubMed ID: 3448770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.